CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net loss	$ (13,066,661)	$ (17,686,472)	$ (7,150,712)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	442,262	206,344	313,940
Impairment of intellectual property		114,730
Stock based compensation expense	1,964,053	1,517,524	1,953,844
Change in fair value of warrant liability	908,005	7,508,146
Amortization of capitalized financing costs			85,975
Amortization of debt discount attributable to convertible debentures			541,120
Fair value of vested warrants issued for service		28,256	58,238
Common stock issued in settlement of interest			102,844
Fair value change from employee option modifications	69,288	408,605
Common stock issued for consulting services	337,501
Bad debt expense	19,755	77,415
Change in operating assets and liabilities:
Accounts receivable	(181,935)	(453,059)	(88,407)
Prepaid expenses and deposits	32,352	(109,042)	(16,565)
Accounts payable and accrued liabilities	527,783	517,200	239,044
Deferred revenue	434,859
Net cash used in operating activities	(8,512,738)	(7,870,353)	(3,960,679)
Cash flows used in investing activities:
Purchase of assets under RedWeb asset purchase agreement		(584,080)
Purchase of property and equipment	(229,591)	(636,548)	(162,833)
Net cash used in investing activities	(229,591)	(1,220,628)	(162,833)
Cash flows from financing activities:
Net proceeds from sale of Series A and Series B Preferred Stock		10,735,000
Net proceeds from sale of common stock and warrants	2,156,264	3,900,000	2,101,000
Proceeds from promissory notes, including $1,000,000 from a related party	1,800,000
Deferred offering costs	(181,104)
Purchase and cancellation of previously issued warrants		(60,000)
Proceeds from exercise of options and warrants		151,500
Net cash provided by financing activities	3,775,160	14,726,500	2,101,000
Net increase (decrease) in cash and cash equivalents	(4,967,169)	5,635,519	(2,022,512)
Cash and cash equivalents at beginning of year	6,360,301	724,782	2,747,294
Cash and cash equivalents at end of year	1,393,132	6,360,301	724,782
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest
Cash paid during period for income taxes
Non-cash investing and financing transactions:
Reclassification of warrants from liability to equity upon exercise of warrants	2,455,042
Property, plant and equipment acquired, and included in accounts payable		6,273
Common stock issued upon conversion of Series A and Series B preferred stock		1,129
Common stock issued for cashless exercise of options and warrants	472	826
Common stock issued in exchange for previously incurred debt and related accrued interest			$ 4,687,096